/world-health-assembly-may-2025.tmb-1200v.jpg?sfvrsn=99fd8183_1 "WHA78: May 24, 2025 - Daily Update")
WHA78: May 24, 2025 – Daily Update
- The World Health Assembly recently approved a series of resolutions addressing critical global health challenges.
- A landmark resolution now designates rare diseases as a global health priority,acknowledging that over 300 million people worldwide live with one of more than 7,000 rare diseases.
- To address a global health financing emergency, member states endorsed a resolution to strengthen health financing globally.
The World Health Assembly took decisive action on May 24, 2025, with key resolutions addressing global health priorities. The assembly recognized rare diseases as a global health priority, directly impacting the lives of over 300 million people worldwide. This landmark decision, a primary_keyword, encourages countries to incorporate rare disease management into national health plans and improve access to affordable treatments. Simultaneously, the assembly fortified global health financing amid potential aid cuts, launching measures to strengthen domestic health budgets and boost financial management. Further, efforts to eradicate Guinea worm disease gained new momentum. skin diseases were also given priority, setting up a plan for thorough solutions. News Directory 3 is following this news closely. Discover what’s next as the WHO operationalizes these resolutions.
WHO Assembly Tackles Rare Diseases, Health Financing, and global Health Priorities
Updated May 25, 2025
The World Health Assembly recently approved a series of resolutions addressing critical global health challenges. These include recognizing rare diseases as a global health priority, strengthening health financing, boosting science-driven health policy, stepping up efforts to eradicate Guinea worm disease, and recognizing skin diseases as a global public health priority.
A landmark resolution now designates rare diseases as a global health priority,acknowledging that over 300 million people worldwide live with one of more than 7,000 rare diseases. These conditions often begin in childhood and can cause significant hardship. The resolution urges countries to integrate rare diseases into national health planning and improve access to affordable treatment, promoting equity and inclusion.
To address a global health financing emergency, member states endorsed a resolution to strengthen health financing globally. This action comes as external aid faces potential reductions, coupled with rising out-of-pocket spending and service disruptions. The resolution outlines actions to bolster domestic health budgets and improve financial management for better population health outcomes.The WHO will play a renewed role in shifting health financing toward country self-reliance and enduring progress.
In a move to enhance evidence-based health systems, a resolution was approved to strengthen national capacities for developing public health guidance grounded in scientific evidence. This decision aims to address gaps in countries’ abilities to generate and use context-specific data. Governments are urged to invest in systems supporting national guideline progress, including regulatory frameworks and local research.
The fight against Guinea worm disease received a boost with a new resolution reaffirming global commitment to eradication. With only 15 human cases reported in 2024, the resolution endorses WHO’s revised eradication strategy, addressing infections in animals that could undermine progress. The WHO recommends an integrated approach combining human, animal, and environmental health efforts.
Recognizing the significant burden of skin diseases, the World Health Assembly adopted a resolution to address these conditions as a global public health priority. The resolution expresses commitment to addressing all conditions affecting the skin, as well as systemic diseases with skin manifestations. it calls for coordinated action, strengthened financing, capacity-building, and access to essential medicines.
What’s next
The WHO is set to operationalize these resolutions by strengthening its technical functions, working with countries to improve public financing, and developing a complete global action plan for rare diseases. These efforts aim to ensure equitable, affordable, and quality health for all.